Clinical trial · Observational
Partial PTEN Deletion in Breast Cancer
Partial PTEN Deletion and Its Relation to Clinicopathological Characteristics in Breast Cancer Patients
NCT05111080CI-TRIAL-00054929unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
* Detection of chromosome 10q23 deletion including PTEN locus in breast cancer patients. * Correlation between PTEN deletion and clinicopathological characteristics in breast cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| PTEN Gene Deletion | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Detection of chromosome 10q23 deletion including PTEN locus in breast cancer patients.
- timeFrame
- baseline
- description
- Correlation between PTEN deletion and clinicopathological characteristics in breast cancer patients.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * all stages of breast cancer in females. Exclusion Criteria: * breast cancer in males.
References
Publications (1)
- BACKGROUNDYoung PA, Kaiser II. Aminoacylation of Escherichia coli cysteine tRNA by selenocysteine. Arch Biochem Biophys. 1975 Dec;171(2):483-9. doi: 10.1016/0003-9861(75)90057-0. No abstract available. PMID 963